Cargando…
Genomic Alterations and Their Implications on Survival in Nonmetastatic Colorectal Cancer: Status Quo and Future Perspectives
The selection of treatment according to genomic alterations is a standard approach in metastatic colorectal cancer but is only starting to have an impact in the earlier stages of the disease. The status if genes like KRAS, BRAF, and MMR has substantial survival implications, and concerted research e...
Autores principales: | Mukherji, Reetu, Marshall, John L., Seeber, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465976/ https://www.ncbi.nlm.nih.gov/pubmed/32707813 http://dx.doi.org/10.3390/cancers12082001 |
Ejemplares similares
-
Biomarkers in Metastatic Colorectal Cancer: Status Quo and Future Perspective
por: Puccini, Alberto, et al.
Publicado: (2022) -
Myconanotechnology in veterinary sector: Status quo and future perspectives
por: Hanafy, Mai Hamed
Publicado: (2018) -
Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy
por: Enevoldsen, Frederik C., et al.
Publicado: (2020) -
Oral delivery of proteins and peptides: Challenges, status quo and future perspectives
por: Zhu, Quangang, et al.
Publicado: (2021) -
Lessons Learned in Managing Patients with Colorectal Cancer During the COVID-19 Pandemic
por: Mukherji, Reetu, et al.
Publicado: (2021)